Trial Profile
The relationship and mechanism of SNPs, AEs and PK in Chinese renal cell carcinoma patients treated with sunitinib
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2016
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 19 Jul 2016 New trial record